Langerhans cell chimerism early after T-cell depleted allogeneic haematopoietic stem cell transplantation

被引：0
|
作者：
Schneiker, K. [1 ]
Schmitt, T. [1 ]
Konur, A. [1 ]
Hemmerling, J. [1 ]
Bender, K. [1 ]
von Stebut, E. [1 ]
Hadian, A. [1 ]
Kolbe, K. [1 ]
Huber, C. [1 ]
Herr, W. [1 ]
Meyer, R. G. [1 ]
机构：
[1] Univ Clin Mainz, Mainz, Germany
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [21] PREDICTORS AND IMPACT OF DONOR T-CELL CHIMERISM IN MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION
    Dean, R. M.
    Sobecks, R.
    Rybicki, L.
    Brown, S.
    Copelan, E.
    Kalaycio, M.
    Pohlman, B.
    Sweetenham, J.
    Andresen, S.
    Bolwell, B. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 109 - 109
  • [22] Complete chimerism after T-cell depleted allogeneic peripheral blood progenitor cell transplantation in hematologic malignancies.
    Schreiner, T
    Maccari, B
    Bischof, C
    Erne, E
    Bunjes, D
    von Harsdorf, S
    Wiesneth, M
    BONE MARROW TRANSPLANTATION, 1998, 21 : S99 - S99
  • [23] No stable mixed chimerism and poor immune reconstitution after major HLA mismatched T-cell depleted allogeneic and autologous stem cell transplantation
    Ringdén, O
    Mattsson, J
    Uzunel, M
    Tammik, C
    Omazic, B
    Levitsky, V
    Zou, JZ
    Hentschke, P
    Remberger, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S231 - S231
  • [24] Allogeneic transplantation of T-cell depleted stem cell grafts followed by T-cell add back.
    Weber-Nordt, RM
    Goldschmidt, H
    Thalheimer, M
    Fruehauf, S
    Goerner, M
    Ho, AD
    BLOOD, 2000, 96 (11) : 399A - 399A
  • [25] Bone Marrow Mixed Chimerism Is a Risk Factor for Relapse After T-Cell Depleted Allogeneic Stem Cell Transplant
    Olson, Amanda L.
    Barker, Juliet N.
    Castro-Malaspina, Hugo
    Devlin, Sean
    Giralt, Sergio A.
    Goldberg, Jenna D.
    Lehrman, Rachel
    Maloy, Molly
    O'Reilly, Richard J.
    Perales, Miguel-Angel
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    BLOOD, 2012, 120 (21)
  • [26] αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
    Kordelas, L.
    Buttkereit, U.
    Lindemann, M.
    Koldehoff, M.
    Klisanin, V.
    Horn, P. A.
    Fleischhauer, K.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2017, 52 (12) : 1668 - 1670
  • [27] αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
    L Kordelas
    U Buttkereit
    M Lindemann
    M Koldehoff
    V Klisanin
    P A Horn
    K Fleischhauer
    D W Beelen
    Bone Marrow Transplantation, 2017, 52 : 1668 - 1670
  • [28] Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma
    Kami, M
    Hamaki, T
    Miyakoshi, S
    Murashige, N
    Kanda, Y
    Tanosaki, R
    Takaue, Y
    Taniguchi, S
    Hirai, H
    Ozawa, K
    Kasai, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (02) : 304 - 309
  • [29] Foscarnet as single agent pre-emptive treatment of cytomegalovirus reactivation after T-cell depleted allogeneic haematopoietic stem cell transplantation
    Ciceri, F
    Lunghi, F
    Pescarollo, A
    Guggiari, E
    Bonini, C
    Servida, P
    Callegaro, L
    Bernardi, M
    Crippa, F
    Bordignon, C
    Bregni, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S319 - S319
  • [30] T-cell chimerism does significantly bias overall chimerism status after T-cell depleted allogeneic stem cell transplantation and is influenced by immunological factors including the conditioning regimen, GvHD and CMV serostatus
    Harskamp, J. C.
    van der Heiden, P. L. J.
    van Egmond, H. M.
    Veld, S. A. J.
    Vos, H. L.
    Halkes, C. J. M.
    Veelken, H.
    Falkenburg, J. H. F.
    Marijt, E. W.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S204 - S204
12345